Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$105,000.00
May 1, 2015
Determinants of Smoking Cessation Success in the Mass Distribution Paradigm of Nicotine Replacement Therapy
$150,000.00
May 1, 2015
Networks, signatures, and personalized medicine: a whole genome approach to cancer therapy
$105,000.00
May 1, 2015
Investigating a tumor suppressor role for Parkinson's susceptibility gene LRRK2 in lung cancer
$105,000.00
May 1, 2015
Improving the efficacy of retinoic-acid-based therapies in triple-negative breast cancer
$135,000.00
May 1, 2015
A personalized allele-specific gene silencing approach for maximal therapeutic coverage of the Huntington disease population
$150,000.00
May 1, 2015
Circumventing Mechanisms of Cancer Therapy Resistance By Targeting DNA Damage Responses in the Tumor Microenvironment
$165,000.00
May 1, 2015
Trends in use of evidence-based therapies and outcomes in patients undergoing percutaneous coronary interventions.
$105,000.00
May 1, 2015
Characterizing the role and regulation of the mammalian tumour suppressor gene Fat4 on metabolism, mitochondrial complex activity and stability
$105,000.00
May 1, 2015
The identification of alternatively spliced genes by the Quaking RNA binding proteins in oligodendrocytes
$150,000.00
May 1, 2015
Exploring Gene/Environment Interaction in the Diabetic Embryopathy Femoral Facial Syndrome